The Avicenna Alliance itself has its origins in the Avicenna Roadmap, a 2-year EU funded project, led by DG Connect whose goal was to create a research and technological development Roadmap outlining a strategy for in silico Clinical Trials (ISCT).

 Built into the European Commission’s project requirements was a plan to establish a pre-competitive Association – the Avicenna Alliance, that would represent the needs of the in silico medicine community and provide the Commission and other policy makers with expert advice in this field.

The Avicenna Alliance operating since 2016, now works with members to implement this Roadmap and identify policy and regulatory obstacles to the enhancement of in silico medicine.

The Avicenna Alliance is a researcher and industry partnership with 50% membership of the Virtual Physiological Human Initiative (VPH) and 50% representation of the medical devices, pharmaceuticals, software and cosmetics industries.

By engaging both researchers and industry in the conversation on how to roll out this roadmap, the Avicenna Alliance is the one stop shop for all things in silico medicine at EU level.

To find out if you could benefit from Membership of the Avicenna Alliance, click here.

The completed Avicenna Roadmap

Downloadable version (5,6 MB)

More information about the Avicenna Roadmap can be found here

Avicenna Alliance news

The Commission adopted a Communication on a new European Research Area for Research and Innovation

On 30 September the European Commission adopted a Communication on a new European Research Area for...

find out more ›

CADFEM Medical ONLINE Conference 2020

Under the motto "in vivo, in vitro, in silico - the central role of in silico medicine - what it can do and what we need for it", this year's specialist...

find out more ›

Avicenna provides feedback to the survey on the pharmaceutical strategy

On 15 September the Avicenna Alliance submitted Member's feedback to the survey on the pharmaceutical strategy! While...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up